Poly-gamma-glutamic acid-containing vaccineAlternative Names: BLS-PGA-C10
Latest Information Update: 26 Nov 2015
At a glance
- Originator Bioleaders Corporation
- Developer Bioleaders Corporation; CJ HealthCare; Tianjin International Joint Academy of Biotechnology and Medicine
- Class Cancer vaccines; Glutamates; Peptides
- Mechanism of Action Immunostimulants; Natural killer cell stimulants
Orphan Drug Status
Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.
On Fast track
Fast track status is assigned by the US FDA so therapies with the potential to address unmet needs can move faster through development.
- New Molecular Entity No
Highest Development Phases
- Phase III Cervical intraepithelial neoplasia